At SHS Capital we are committed to Building European Healthcare Champions, by helping to accelerate our portfolio companies' growth. We do that by following high ethical and sustainable standards. If you are looking for the right partner to bring your Healthcare company to the next level, reach out! https://www.shs-capital.eu/ We focus on Phases: Growth cases and “Mittelstand” companies Regions: DACH, Benelux, and the Nordics?Industries: Life science, Medical technology, Diagnostics, Digital health, Applied technologies, and industrial biotechnology & pharmaceuticals (no drug development) Investors can participate in a diversified portfolio of innovative companies from the life science and medical technology sector via SHS funds. Our investor base comprises private and institutional investor groups with a long-term focus. We currently host investors from well-known family offices, pension funds, pension schemes, fund of funds, banks, churches, health insurance companies, industrial companies, the European Investment Fund, and the KfW." title="" class="btn" data-container="body" data-html="true" data-id="254378" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="SHS Capital"> 4,831
Entity types
Location
Bismarckstraße 12, 72072 Tübingen, Germany
Tübingen
Germany
Employees
Scale: 11-50
Estimated: 48
Engaged corporates
1Added in Motherbase
2 months agoBuilding European Healthcare Champions
At SHS Capital we are committed to Building European Healthcare Champions, by helping to accelerate our portfolio companies' growth. We do that by following high ethical and sustainable standards. If you are looking for the right partner to bring your Healthcare company to the next level, reach out!
https://www.shs-capital.eu/
We focus on
Phases: Growth cases and “Mittelstand” companies
Regions: DACH, Benelux, and the Nordics?Industries: Life science, Medical technology, Diagnostics, Digital health, Applied technologies, and industrial biotechnology & pharmaceuticals (no drug development)
Investors can participate in a diversified portfolio of innovative companies from the life science and medical technology sector via SHS funds. Our investor base comprises private and institutional investor groups with a long-term focus. We currently host investors from well-known family offices, pension funds, pension schemes, fund of funds, banks, churches, health insurance companies, industrial companies, the European Investment Fund, and the KfW.
Life Sciences, MedTech, Diagnostics, Digital Health, Industrial Biotechnology (no drug development), Growth capital, Management Buy In/Out, M&A financing, IPO, Spin-off, Internalization, Expansion, Private Equity, and Succession
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() HTGF | High-Tech Gründerfonds Venture Capital and Private Equity Principals | HTGF | High-Tech Gründerfonds Venture Capital and Private Equity Principals | Other 13 Mar 2025 | |